Nucleus Accumbens and Dopamine-Mediated Turning Behavior of the Rat: Role of Accumbal Non-dopaminergic Receptors

Accumbal dopamine plays an important role in physiological responses and diseases such as schizophrenia, Parkinson's disease, and depression. Since the nucleus accumbens contains different neurotransmitters, it is important to know how they interact with dopaminergic function: this is because m...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiroko Ikeda (Author), Junzo Kamei (Author), Noriaki Koshikawa (Author), Alexander R. Cools (Author)
Format: Book
Published: Elsevier, 2012-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6d73af6f10c54a0f9219ccf1b7f25890
042 |a dc 
100 1 0 |a Hiroko Ikeda  |e author 
700 1 0 |a Junzo Kamei  |e author 
700 1 0 |a Noriaki Koshikawa  |e author 
700 1 0 |a Alexander R. Cools  |e author 
245 0 0 |a Nucleus Accumbens and Dopamine-Mediated Turning Behavior of the Rat: Role of Accumbal Non-dopaminergic Receptors 
260 |b Elsevier,   |c 2012-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.12R02CR 
520 |a Accumbal dopamine plays an important role in physiological responses and diseases such as schizophrenia, Parkinson's disease, and depression. Since the nucleus accumbens contains different neurotransmitters, it is important to know how they interact with dopaminergic function: this is because modifying accumbal dopamine has far-reaching consequences for the treatment of diseases in which accumbal dopamine is involved. This review provides a summary of these interactions, and our current knowledge about them are as follows: A) AMPA receptors are required for dopamine-dependent behavior and vice versa; NMDA receptors modulate the activity at the level of AMPA and/or dopamine D1 receptors. B) GABAA, but not GABAB, receptors inhibit dopamine-dependent behavior. C) Nicotinic receptors are required for dopamine-dependent behavior, whereas muscarinic receptors inhibit dopamine-dependent behavior. D) α-Adrenoceptors inhibit dopamine-dependent behavior in contrast to β-adrenoceptors, which potentiate this behavior. E) μ- and δ2-opioid receptors elicit behavior that requires an intact dopaminergic function and δ2-opioid receptors modulate dopamine-dependent behavior. F) Orexin 2 receptors play an important, modifying role in dopamine-dependent behavior. G) Somatostatin receptors potentiate dopamine-dependent behavior. It is suggested that modulation of the above-mentioned nondopaminergic receptors provide new tools to control physiological functions as well as diseases mediated by accumbal dopamine. Keywords:: dopamine, nucleus accumbens, turning behavior 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 120, Iss 3, Pp 152-164 (2012) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S134786131930430X 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/6d73af6f10c54a0f9219ccf1b7f25890  |z Connect to this object online.